Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural... see more

GREY:ISCNF - Post Discussion

Isracann Biosciences Inc > IPOT poised to become largest weed producer in Israel
View:
Post by Alexandchoy on Feb 25, 2021 2:45pm

IPOT poised to become largest weed producer in Israel

2017 surveys showed Israel held the record for the world’s highest ratio of marijuana users with 27% of the population aged 18-65 identifying as recreational users. They are finally now moving to legalization. 

 

“This is a significant, holistic and responsible reform, which shows the State of Israel isn’t ignoring reality and is going in the footsteps of developed countries.” - Justice Minister of Israel Avi Nissenkorn on legalization of weed recreationally.

 

Israel = population of 9M and 27% are recreational smokers = they are in short supply right now. When legalization comes IPOT will import from partners in Canada to capture short term spike in demand as they ramp up domestic production. 

 

IPOT has a completed 55k sq ft facility for domestic production that will service medical needs and another 110k sq ft facility underway to supply recreational market.

 

They are poised to become the largest producer in Israel and one of the largest exporters in Europe. 

 

IPOT only has $50M market cap and 138M shares out. Given their positioning to capture market share I think this has multi bagger potential. 

Comment by CBSindustries on Feb 27, 2021 9:39am
Appreciate your daily posts A&c. Your enthusiasm is infectious. You sure have scared off the short sellinug vultures. Where are they all now? I have been an IPOT investor since they first listed and watched them grow. With European and world recreational and medical markets opening up this company is poised for fantastic gains.